Here are relevant reports on : plasma-cutting-machine-market
-
Electromagnetic Weapons Market by Product (Lethal Weapons, Non-lethal Weapons), Application (Homeland Security, Military), Platform (Land, Naval, Airborne), Technology (Particle Beam Weapons, Laser-induced Plasma Channel), and Region - Global Forecast to 2035
The Electromagnetic Weapons Market is emerging as a strategically significant segment within the global defense industry, driven by the increasing need for advanced, non-kinetic warfare capabilities. The market was valued at approximately USD 6.0–8.0 billion in 2025 and is projected to reach USD 14.0–18.0 billion by 2035, expanding at a CAGR of around 7%–9% during the forecast period. Growth is fueled by rising geopolitical tensions, modernization of military forces, and the demand for precision strike capabilities with minimal collateral damage.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Bone Growth Stimulator Market by Product (Device (External Bone Growth Stimulators), Platelet-Rich Plasma), Application (Spinal Fusion Surgeries, Oral & Maxillofacial Surgeries), End User (Hospital, Ambulatory Surgical Centers) & Region - Global Forecast to 2027
The global bone growth stimulator market in terms of revenue was estimated to be worth $1.4 billion in 2022 and is poised to reach $1.8 billion by 2027, growing at a CAGR of 5.9% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: October 2022
- Price: $ 4950
- TOC Available:
-
Bleeding Disorders Treatment Market by Type (Hemophilia A, Hemophilia B, vWD), Drug Class (Plasma Derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antibrinolytics, Fibrin Sealant) - Global Forecast to 2021
The global bleeding disorders treatment market size is projected to grow at a CAGR of 7.9%. The major factors driving the market growth include the growing patient population base, R&D activities, and increasing focus on recombinant products by pharmaceutical companies. Emerging markets offer significant growth opportunities for the bleeding disorders treatment market.
- Published: July 2016
- Price: $ 4950
- TOC Available:
-
Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) - Global Forecast to 2028
The global plasma fractionation market, valued at US$27.2 billion in 2022, stood at US$29.0 billion in 2023 and is projected to advance at a resilient CAGR of 6.9% from 2025 to 2028, culminating in a forecasted valuation of US$40.4 billion by the end of the period. Market growth is driven mainly by factors such as the growing use of immunoglobulins in various therapeutic areas, strategic expansion of plasma collection centers/inventories by market players, and the growing prevalence of respiratory diseases and AATD
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Dielectric Materials Market in Electronic Displays - By Technology (LCD, LED, TFT-LCD, OLED, LCOS, Display, DLP, Plasma), Application (Conventional, 3D, Transparent, Flexible Display), & By Geography - Forecast & Analysis (2013 -2020)
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Hemophilia Treatment Market by Indication (Type A, Type B), Therapy (Replacement (Recombinant, Plasma Derived), Route of Administration, End User - Global Forecast to 2027
The global hemophilia treatment market is projected to reach USD ~15 billion by 2027 from USD 12 Billion in 2022, at a CAGR of 5% during the forecast period. The major players in the global hemophilia market are Bayer Healthcare (Germany), Octapharma AG (Switzerland), Novo Nordisk (Denmark), Kedrion (Italy), Pfizer Inc. (US), Biogen (US) among others.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Inorganic Mass Spectrometry Market by Product (Inductively Coupled Plasma-Mass Spectrometry, Isotope Ratio Mass Spectrometry) & Application (Nuclear Science, Metrology, and Industrial Chemistry) - Analysis & Global Forecast to 2020
Inorganic Mass spectrometry is an analytical technique used for multi elemental determination of elements at the trace and ultratrace level in high-purity materials. The mass spectrometry market is segmented on the basis of product and application. The mass spectrometry market, by product, is segmented into isotope ratio mass spectrometry (IRMS), multi-collector mass spectrometry (MC/IRMS), inductively coupled plasma mass spectrometry (ICP/MS), and high resolution trace mass spectrometry (HR Trace/MS)
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Laboratory Freezers Market by Product(Cryopreservation, Plasma Freezer, ExplosionProof Freezer, Enzyme Freezer, Ultra-Low Freezer, Blood Bank Refrigerator, Pharmacy Refrigerator, Chromatography Refrigerator), End User(Hospitals) - Global Forecast to 2026
The global laboratory freezers market in terms of revenue was estimated to be worth $4.7 billion in 2022 and is poised to reach $5.7 billion by 2026, growing at a CAGR of 4.9% from 2022 to 2026. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: August 2021
- Price: $ 4950
- TOC Available:
-
Exosome Diagnostics and Therapeutics Market by Type (Diagnostics, Therapeutics), Product & Service (Instruments, Kits, Reagents), Source (Stem Cells, Blood, Blood Plasma, Urine), Application (Cancer, Musculoskeletal, CVD) - Global Forecast to 2032
The global exosome diagnostics and therapeutics market, valued at US$33 million in 2023, stood at US$59 million in 2024 and is projected to advance at a resilient CAGR of 81.2% from 2024 to 2032, culminating in a forecasted valuation of US$6,848 million by the end of the period. The growth of this market is driven by factors such as the increasing collaborations & commercialization initiatives, emerging potential of exosome-based liquid biopsy, and growing outsourcing of exosome manufacturing activities.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
In Vitro Diagnostics (IVD) Quality Control Market by Product & Service (QC (Plasma, Serum, Blood), Solutions), Technology (Immunoassay, MDx, Microbiology, Hematology), Manufacturer (Third-party, OEM), End User (Hospitals, Labs) - Global Forecast to 2030
The global IVD quality controls market, valued at US$1.58 billion in 2024, stood at US$1.65 billion in 2025 and is projected to advance at a resilient CAGR of 5.5% from 2025 to 2030, culminating in a forecasted valuation of US$2.15 billion by the end of the period. The IVD quality controls market is witnessing substantial growth, driven by several key factors.
- Published: September 2025
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
